[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"abortion-early\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:abortion-early":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100625065","point-of-care-tests-in-the-management-of-very-early-medical-abortion-100625065",false,"NCT07417787","Point of Care Tests in the Management of Very Early Medical Abortion","Point of Care Testing for Human Chorionic Gonadotropin (HCG) to Improve Access to Very Early Medical Abortion and Simplify the Follow up Process","POCT VEMA","Inclusion Criteria:\n\n* Positive pregnancy test\n* Less than six weeks gestation based upon Last Menstrual Period (LMP)\n* No evidence of definite intrauterine pregnancy on ultrasound\n* No signs or symptoms or significant risk factors for ectopic\n* Wish to proceed to VEMA (Very Early Medical Abortion)\n* Available for usual clinical follow up\n* Willing to attend for serum Human Chorionic Gonadotropin (HCG) on two occasions Day 2-4 and Day 7 post mifepristone\n* Written informed consent\n\nExclusion Criteria:\n\n* Pain and\u002For bleeding\n* Significant risk factors for ectopic (previous ectopic, sterilisation, tubal disease, intrauterine device in situ)\n* Suspicious features for ectopic on ultrasound (adnexal mass, moderate free fluid)\n* Unable to provide blood sample\n* Lack of Capacity to consent","FEMALE","16 Years","55 Years",{"count":21,"type":22},130,"ESTIMATED","OBSERVATIONAL","This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \\\u003C6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.",[26],"Abortion Early",[28,29,30,31],"VEMA","Very Early Medical Abortion","point of care test","POCT","RECRUITING","2026-06-01",{"date":35,"type":36},"2026-06-03","ACTUAL",{"date":38,"type":36},"2026-04-23",{"date":40,"type":22},"2028-02",{"name":42,"class":43},"University of Edinburgh","OTHER",3,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100576590","research-on-equity-in-abortion-care-by-telehealth-100576590","NCT06787274","Research on Equity in Abortion Care by TeleHealth","Improving Health Equity by Understanding Preferences in Telehealth Abortion","REACH","Inclusion Criteria:\n\n* Must be currently or about to be obtaining medication abortion care through in-person or telehealth services\n\nExclusion Criteria:\n\n* Not currently or about to be obtaining medication abortion care through in-person or telehealth services",true,"ALL","14 Years","64 Years",{"count":58,"type":22},2000,"This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested, eligible participants: 2,000 patients seeking abortion care will complete the study, comprising of 2 groups: patients seeking medication abortion care either (1) in-person or (2) via telehealth. This project will address how telehealth services can be optimized for people of color, low-income people, and immigrants to increase digital inclusion and health equity.",[61,26,62],"Abortion in First Trimester","Abortion; Attempted",[64,65,66],"health equity","medication abortion","telehealth","2026-04-06",{"date":69,"type":36},"2026-04-08",{"date":71,"type":36},"2025-02-12",{"date":73,"type":22},"2026-08-31",{"name":75,"class":43},"University of California, San Francisco",1]